GSK And Isis Pharmaceuticals Collaborate On RNA Therapeutics For Rare And Infectious Diseases

Links shared publicly online about this topic.

  • 1,267
    total visits

GSK And Isis Pharmaceuticals Collaborate On RNA Therapeutics For Rare And Infectious Diseases

medicalnewstoday.com —

GlaxoSmithKline (NYSE: GSK) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new

View full resource at medicalnewstoday.com

Tags: Infectious Disease, Infection, Disease and Condition, Drug, Pharma, GlaxoSmithKline

  • Share

Most Recently Shared on April 3, 2010 at 4:05 pm By:

mnt_diseases MNT Infect Diseases

GSK And Isis Pharmaceuticals Collaborate On RNA Therapeutics For Rare And Infectious Diseases http://mnt.to/3zNg #viruses #bacteria

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Pharma News MNT Pharma News

Advertisement